Malaysian retailer Mr DIY revives US$500m IPO plan
[KUALA LUMPUR] Malaysia's Mr DIY Group is reviving its initial public offering plan after postponing it in March when the Covid-19 pandemic worsened, according to people with knowledge of the matter.
The country's biggest home improvement retailer aims to restart marketing to gauge investors' interest next month, the people said. The company aims to raise about US$500 million in the share sale, which could begin as early as October, the people said, asking not to be named as the information is private.
Mr DIY's sales surged to a record in May and June, after the government partially lifted coronavirus-driven restrictions in order to resuscitate the economy, the people said.
The share sale by the company, which is backed by private equity firm Creador, would be the biggest IPO in Malaysia since Lotte Chemical Titan Holding raked in US$849 million in 2017, according to data compiled by Bloomberg.
The potential deal will give a boost to the Malaysian stock market, which has only seen US$70.7 million worth of IPOs so far this year, the slowest in more than a decade. Despite the political turmoil in the country, the benchmark FTSE Bursa Malaysia KLCI Index has rebounded nearly 30 per cent from its March low.
Deliberations on the plan are still ongoing and there is no certainty the company will proceed, said the people. Representatives for Creador and Mr DIY declined to comment.
A NEWSLETTER FOR YOU
Asean Business
Business insights centering on South-east Asia's fast-growing economies.
Mr DIY opened its first store in Malaysia in 2005 and now operates more than 622 outlets across the country, according to its website. The company sells over 14,000 types of products in ten categories including furniture, computer accessories, hardware and toys. It counts Tesco Plc and Aeon among its business partners.
BLOOMBERG
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue